PHA Pharmagest Interactive SA

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR

Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the 2026 financial year.

EventsDates
2025 annual revenueFebruary 5, 2026 (after market close)
2025 annual resultsMarch 30, 2026 (before market opens)
2026 Q1 revenueApril 29, 2026 (after market close)
Annual General MeetingJune 25, 2026
2026 Half-year revenueJuly 30, 2026 (after market close)
2026 Half-year resultsSeptember 28, 2026 (before market opens)
2026 Q3 revenueOctober 29, 2026 (after market close)



About the Equasens Group

Founded over 35 years ago, Equasens Group, a leader in digital healthcare solutions, today employs over 1.400 people across Europe.         

Equasens Group’s specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as data hosting, financing and training adapted to their specific needs.         

And reflecting the spirit of its tagline "Technology for a More Human Experience", the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient and secure healthcare system.

Listed on Euronext Paris™ - Compartment B Indices: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable by inclusion        .

Listed on Euronext Tech Leaders and the European Rising Tech label Eligible for the Deferred Settlement Service (SRD) and the PEA-PME scheme. ISIN: FR 0012882389 – Ticker symbol: EQS

Find all the latest news about the Equasens Group at and on LinkedIn

Contact

EQUASENS Group

Investor Relations



Chief Financial Officer: Frédérique SCHMIDT

Tel.: +33 (0)3 83 15 90 67

NewCap

Investor Relations

Thomas Grojean

Louis-Victor Delouvrier

Tel: +33 (0)1 44 71 94 94

NewCap

Financial Media Relations

Nicolas Mérigeau

Tel: +33 (0)1 44 71 94 94

Attachment



EN
10/12/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pharmagest Interactive SA

 PRESS RELEASE

EQUASENS ANNONCE SON AGENDA FINANCIER 2026

EQUASENS ANNONCE SON AGENDA FINANCIER 2026 Villers-lès-Nancy, 10 décembre 2026, 18h00 CET – Equasens (isin : FR0012882389 – Mnémo : EQS), leader des solutions numériques pour les professionnels de santé, annonce son agenda financier pour l’exercice 2026. ÉvénementsDatesChiffre d’affaires annuel 20255 février 2026 (après bourse)Résultats annuels 202530 mars 2026 (avant bourse)Chiffre d’affaires du 1er trimestre 202629 avril 2026 (après bourse)Assemblée Générale Annuelle25 juin 2026Chiffre d’affaires du 1er semestre 202630 juillet 2026 (après bourse)Résultats du 1er semestre 202628 septembre ...

 PRESS RELEASE

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the 2026 financial year. EventsDates2025 annual revenueFebruary 5, 2026 (after market close)2025 annual resultsMarch 30, 2026 (before market opens)2026 Q1 revenueApril 29, 2026 (after market close)Annual General MeetingJune 25, 20262026 Half-year revenueJuly 30, 2026 (after market close)2026 Half-year resultsSeptember 28, 2026 (before market opens)202...

Aurelien Sivignon
  • Aurelien Sivignon

Equasens : e-health pure player with modest valuation

Equasens provides IT solutions and software for the healthcare industry. Historically positioned in the pharmacy segment (market leader in France, >40% market share), its global expansion (Italy, Germany) and business diversification (nursing homes, hospitals, private practitioners, etc.), should facilitate the return to a dynamic growth trajectory (2025-28 CAGR estimated at +7%) after two challenging years. Given the necessary investments (R&D, salesforce), we believe 2025 will mark a low for m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch